WAT

Waters Corporation

Technology
379.77 +7.84 +2.11% Market Closed
2026-06-03 • USD

Key Metrics

Market Cap 37.29B
EV —
Shares Out 98.19M
Revenue (ttm) 3.77B
Net Income 449.63M
Beta —
P/E —
Forward P/E —
EPS (ttm) $7.86
P/S —
P/B —
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 3.06%
ROE 5.1%
ROIC 2.53%
Gross Margin —
Oper. Margin 16.01%
Profit Margin 11.93%
Debt/Eq 0.34
LT Debt/Eq 24.1%
Quick Ratio —
Current Ratio 1.79
Book/sh —
Cash/sh —
Div Yield —
Div TTM —
Payout Ratio —
SMA20 8.45%
SMA50 16.0%
SMA200 11.31%
Volume 920,400
Avg Volume 1.18M
Rel Volume —
Perf Week -0.99%
Perf Month 10.87%
Perf Quarter 20.34%
Perf Half Y -3.81%
Perf YTD -0.02%
Perf Year 9.66%
Perf 3Y 46.32%
Perf 5Y 18.95%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Waters Corporation is a global leader in analytical instruments and software that has pioneered innovations in chromatography, mass spectrometry and thermal analysis serving life, materials and food sciences for more than 65 years. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are frequently employed together as LC-MS and sold as integrated instrument systems using common software platforms. Products are used by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic and governmental customers. The Company also designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments product line, and develops and supplies advanced software-based products that interface with its instruments as well as other manufacturers' instruments. Following the February 2026 acquisition of BD's Biosciences and Diagnostic Solutions businesses, the Company has reorganized into four segments: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics and Waters Materials Sciences, now offering capabilities in cellular and molecular diagnostics, flow cytometry, microbiology, and molecular testing.

Name
Waters Corporation
Industry
Technology
CEO
Udit Batra · President and Chief Executive Officer
Employees
16,000 as of 2026-02-09
IPO Date
2014-12-09
Phone
(508) 478-2000
Address
34 Maple Street, Milford, MA 01757
Website
ir.waters.com

Key Executives

Name Title FY Pay
Dan Brennan Independent Director, Audit & Finance Committee Member —
Linda Baddour Independent Director, Chair of Audit & Finance Committee —
Flemming Ørnskov Chair of the Board —
Keeley A. Aleman Senior Vice President, General Counsel and Secretary —
Udit Batra President and Chief Executive Officer —

Latest News